In chronic autoimmune diseases such as systemic lupus erythematodus (SLE), surplus activation of CAMK is associated with disruptions of the balance of TREGs and TH17cells and suppression of IL-2 production52–54. This evidence concerns the gene CAMK4 and systemic lupus erythematosus.